The Harvard Drug Group LLC recalls Carton Label: MAJOR
- Recalling company
- The Harvard Drug Group LLC
- Product
- Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
- Reason
- Subpotent Drug
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 16, 2026
- Reported
- Jul 1, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 790 Cartons.
- Lot / codes
- Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
- Company location
- Dublin, OH
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0609-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0609-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.